How is Mesoblast a 2b market cap? Their earnings for last year are almost entirely an accounting trick. The rest is 4 year amortization of a 130 mil Cephelon deal. They have several up coming phIII trials. I guess they do have >250 mil in cash. Anyone wish to comment on the IP differences between Mesoblast and Osiris?